Michelle Lock

Chief Executive Officer at RELIEF THERAPEUTICS HOLDING SA

Health Technology

Profile

Michelle Lock is currently the Chief Executive Officer & Director at RELIEF THERAPEUTICS Holding SA. Previously, she held the position of Senior Vice President, Head-Europe & International at Acceleron Pharma, Inc. and Chief Operating Officer at Covis Pharma Holdings BV.

Michelle Lock active positions

Companies	Position	Start
RELIEF THERAPEUTICS HOLDING SA	Chief Executive Officer	2023-10-31

All active positions of Michelle Lock

Former positions of Michelle Lock

Companies	Position	End
Covis Pharma Holdings BV Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland.	Chief Operating Officer	-
ACCELERON PHARMA INC.	Corporate Officer/Principal	-

See the detail of Michelle Lock's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michelle Lock's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
RELIEF THERAPEUTICS HOLDING SA	Health Technology

Private companies	2
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.	Health Technology
Covis Pharma Holdings BV Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland.	Health Technology